FTC OKs Novo-Catalent deal, in major win for Novo Nordisk’s GLP-1 manufacturing

After some delay, the Federal Trade Commission has approved Novo Holdings’ $16.5 billion acquisition of Catalent, a week following the European Commission's go-ahead. Now that both regulatory parties have approved the merger, the transaction will ...